Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01887054 · ClinicalTrials.gov registry record · NA

Freezing of Gait in Parkinson's Disease

A NA study, sponsored by Duke University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT01887054: Completed NA study, sponsored by Duke University.

NCT01887054 is a NA study that has completed, run by Duke University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01887054, a NA study, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

This study is designed to evaluate whether a specific visuospatial training task will change gait performance of Parkinson's disease (PD) patients in doorways, specifically freezing of gait.

Primary Outcome

Primary outcome will be the percent of the gait cycle spent in DLS. This will be evaluated using a GaitRite via a continuous walk, with subjects walking an 18-20 meter oval loop three times continuously.

Interventions

  • DEVICE Tower of Hanoi
  • OTHER Placebo group - non use of Tower of Hanoi

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-06
Est. Completion 2014-08
Phase NA
Duke University

1,725 total trials

What the finished NCT01887054 record still lists

NCT01887054 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Tower of Hanoi is the first listed.

NCT01887054 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01887054 about?

NCT01887054 is a clinical study titled "Freezing of Gait in Parkinson's Disease". This study is designed to evaluate whether a specific visuospatial training task will change gait performance of Parkinson's disease (PD) patients in doorways, specifically freezing of gait.

What is the current status of trial NCT01887054?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-06. Estimated completion is 2014-08.

What interventions are being tested in trial NCT01887054?

The interventions under investigation include: Tower of Hanoi (DEVICE), Placebo group - non use of Tower of Hanoi (OTHER).

Who is sponsoring clinical trial NCT01887054?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01887054's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01887054, the US trial registry maintained by the National Library of Medicine. NCT01887054 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.